
Your Guide to Navigating the Medicare Physician Fee Schedule Tool
The Centers for Medicare & Medicaid Services (CMS) physician fee schedule tool allows healthcare professionals and community-based organizations to find payment information for many Original Medicare services.
The Centers for Medicare & Medicaid Services (CMS) updates the physician fee schedule (PFS) each year. This provides physicians and community-based organizations (CBOs) with a search tool to find the most up-to-date reimbursement rates for various services covered by Original Medicare (Part A and Part B).
What is the PFS?
The PFS is the main method of payment for healthcare professionals who are enrolled in Medicare. Medicare uses the PFS when paying for the following Original Medicare services:
diagnostic tests
radiology services
services provided by auxiliary personnel, like nurses, or by nonphysician practitioners, like nurse practitioners
professional services by physicians and other healthcare professionals in a private practice
A note on Medicare Advantage
Medicare Advantage (Part C) may have different reimbursement rates. It is important to check with each plan for its specific rates and requirements.
About the PFS lookup tool
The CMS provides a PFS lookup tool for physicians and CBOs to find Medicare payment information for more than 10,000 services. These services include:
payment policies
pricing
associated relative value units (RVUs), used to help determine payment for physicians
CBOs may find the lookup tool useful to find reimbursement rates for their specific services, such as:
diabetes self-management training (DSMT)
chronic care management (CCM)
health behavior assessment and intervention (HBAI) services
PFS example 1
The following steps show an example of how to use the PFS lookup tool.
Go to the PFS lookup tool overview and click the 'Begin Search' button. This will take you to the license for use of current procedural terminology. Scroll down and press 'Accept.' Once you do, you will reach the search tool.
For this example, we will search for the reimbursement rate for group DSMT.
Dropdown options in PFS lookup tool
The PFS lookup tool gives dropdown options for:
year
type of information
pricing information
payment policy indicators
relative value units
geographic practice cost index
HCPCS code and criteria
single code
list of codes
range of codes
modifier
Medicare Administrative Contractor (MAC) option
national payment amount
specific MAC
specific locality
all MACs
Let's look at this example together:
For the year, ensure that the current year (2025) is selected.
In the type of information box, select pricing information.
For the HCPCS criteria, ensure that single HCPCS code is selected, then type in G0109.
Modifiers indicate whether a service was altered by a specific circumstance but didn't change its code or definition. Select all modifiers.
For the MAC option, select national payment amount.
Click the Search Fees button.
Search results
The search results show a lot of data. However, for this example, we will focus on the non-facility price, displayed in the results table.
The term 'non-facility' means a service was provided in an office. There may also be a 'facility price,' which means the service was provided in a hospital or ambulatory surgical center.
We are focusing on the non-facility price for this example because this type of DSMT is an outpatient service covered by Medicare Part B.
The search shows us that non-facility group DSMT is reimbursed at a rate of $15.20 per person, per 30 minutes.
These services may be subject to coinsurance. For most Part B services, the beneficiary is responsible for paying 20% of the Medicare-approved costs, leaving 80% for Medicare to pay.
PFS example 2
For this example we will change up our search a bit. This time we will search for two HCPCS codes. We will use the same group DSMT code of G0109 and add an individual DSMT code of G0108. Both of these are billed in 30-minute increments.
This time, we want to find the pricing for a specific location. For this example, we will focus on the Los Angeles area.
Let's look at this example:
Keep the current year (2025).
For the type of information, once again, select pricing information.
The HCPCS criteria select list of HCPCS codes.
This makes two boxes appear. In the first box, put G0108. In the second box, type G0109.
For the modifiers select all modifiers.
For the MAC option, select specific locality.
From the MAC locality dropdown, select 0118218 Los Angeles-Long Beach-Anaheim.
Search results
This time, you can see that the results show the prices for each type of DSMT. The results also show the MAC locality.
This shows that the non-facility price for individual DSMT is $58.26 per 30 minutes. For the group DSMT, the non-facility price is $16.76 per person per 30 minutes.
Finding help
For more help and information about the PFS lookup tool, the CMS provides a quick reference guide.
Summary
The PFS is the main payment method for healthcare professionals enrolled in Medicare. The CMS provides a PFS lookup tool so healthcare professionals and CBOs can search for the most up-to-date reimbursement amounts for specific services.
The CMS updates the PFS each year.
The information on this website may assist you in making personal decisions about insurance, but it is not intended to provide advice regarding the purchase or use of any insurance or insurance products. Healthline Media does not transact the business of insurance in any manner and is not licensed as an insurance company or producer in any U.S. jurisdiction. Healthline Media does not recommend or endorse any third parties that may transact the business of insurance.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Health Line
37 minutes ago
- Health Line
The Link Between Ibuprofen and Ulcers
Long-term ibuprofen use can increase your risk of bleeding and ulcers in your stomach and intestines. If you take ibuprofen regularly, you can take steps to prevent peptic ulcers and protect stomach health. Peptic ulcers are slow-healing sores that can develop in your stomach lining, the beginning or top part of your small intestines (duodenum), or your esophagus. If you have a peptic ulcer, you'll usually experience some degree of abdominal pain. This pain can range from mild to severe and tends to come and go. Some people describe this pain as dull, while for others, it has more of a burning sensation. You might feel this pain anywhere from your belly button to your chest. Other symptoms include: Peptic ulcers can develop for a few reasons. One common cause is the frequent use of nonsteroidal inflammatory drugs (NSAIDs), including ibuprofen (Advil), naproxen (Aleve), and aspirin. Another is infection. Read on to learn how ibuprofen affects your stomach and what you can do to lower your risk of ulcers. Can ibuprofen cause stomach ulcers? Your body produces hormones called prostaglandins, which help heal tissue damage and injury, play a role in ovulation and labor, and help gut muscles contract and relax. These hormones also benefit your stomach in two main ways. They help repair and heal any damage to the lining of your stomach. They also protect your stomach from damage through the production of stomach mucus, which helps counter the effects of the stomach acid that helps break down your food. Stomach acid is very strong — strong enough to wear down your teeth and bones. If your body doesn't produce enough prostaglandins, this acid can easily damage your stomach lining. This is where ibuprofen and other NSAIDs can pose a danger. If you have an infection or injury, your body produces prostaglandins to help you heal. In some cases, though, your body may produce too much of these hormones. High levels of prostaglandins can lead to pain, swelling, and other inflammation. Ibuprofen relieves these symptoms by reducing the amount of prostaglandins your body can produce. But over time, the drop in prostaglandins can leave your stomach more vulnerable to damage. Ulcers don't develop overnight You probably won't develop an ulcer after taking ibuprofen for a few days in a row. Still, regular doses of ibuprofen daily for weeks or months will increase your chances of developing a peptic ulcer. take ibuprofen with other NSAIDs take ibuprofen with some other medications, such as corticosteroids, blood thinners, serotonin-norepinephrine reuptake inhibitors (SNRIs), or selective serotonin reuptake inhibitors (SSRIs) have a history of stomach ulcers have an H. pylori infection are older than 65 have three or more servings of alcohol a day smoke cigarettes Reducing your risk Most people can safely take ibuprofen to relieve short-term symptoms, such as fever, menstrual cramps, or body aches and pains. When taking ibuprofen or any other medication, you can reduce your risk of unwanted side effects by reading the label and following the directions closely. These tips can also help lower your chances of developing an ulcer: Take the smallest possible dose: Does your medication bottle say, 'Take 1 to 2 tablets every 4 to 6 hours?' It never hurts to start with one tablet and pay attention to your symptoms before taking more. Avoid taking too many doses: When taking ibuprofen around the clock to relieve pain that remains for a few days, like menstrual cramps, it may help to set a timer for each dose. If you take your next dose too soon, you may take more ibuprofen than planned and exceed the daily recommendation. Take ibuprofen for no more than a few days at a time: If you have persistent fever, aches, or other symptoms, it may be worth asking your healthcare professional about other options for treating your pain. Keep in mind, too, that NSAIDs to treat migraine pain and other headaches could lead to medication overuse headaches. Medications that help prevent peptic ulcers Many people take ibuprofen regularly to treat arthritis and other conditions that cause chronic pain and inflammation. If you need to take an NSAID long term, consider asking your doctor about medication to help protect against ulcers. The following medications could make a difference: proton pump inhibitors (PPIs), which help lower stomach acid production H2 blockers, which also help lower stomach acid production misoprostol, which helps boost the production of stomach mucus These medications may not work well for everyone and may cause some side effects, including constipation and diarrhea. Also, long-term use of PPIs may increase your risk of fractures and infection. Your care team can offer more guidance on whether these medications are a good option for you. Bottom line Most people won't get an ulcer from taking ibuprofen occasionally, especially when sticking to the dosing directions on the label. Taking several doses of ibuprofen a day for a few weeks or longer may raise your risk of peptic ulcers, especially if you take other NSAIDs at the same time. If you use ibuprofen to manage ongoing pain and inflammation, a good next step involves asking a doctor about medications that can lower your ulcer risk. They can also offer more guidance on other options for pain relief.
Yahoo
an hour ago
- Yahoo
Jaffa Shrine hosts annual ‘Walk for Love' despite rainy weather
ALTOONA, Pa. (WTAJ) — Sunday's rain couldn't stop people from supporting children who need medical care. Despite the rain, the annual 'Walk for Love' took place inside the Jaffa Shrine. The 1-mile walk usually starts on Broad Avenue and turns onto 29th Street. The walk supports Shriners Children's Philadelphia who provides care for children with fractures, sports injuries, orthopedic conditions, scoliosis, spinal cord conditions and spine injuries. 'Every dollar we raise, you know, it goes to the Philadelphia hospital and allows them to buy equipment and that kind of thing. So it is hugely important that we get a big support for this and the hospitals, they so much appreciate everybody that comes out here,' Gary Smith, 2025 Potentate for Jaffa Shriners said. This year's walk saw a decline in attendance, but Smith said they're looking to raise just as much as last year. Johnstown community walks to raise funds for cancer patients Children from all over the Commonwealth are transported to Shriners Hospital in Philadelphia, including children from Blair and surrounding counties. 'Without that need for that hospital, these children would be handicapped for life. So, it's a lifesaving experience for those children. And we really need the community to support us and what we're doing for these children in the area,' Lawrence Maasaro, a Road Runner for the Jaffa Shriners said. For future events at the Jaffa Shrine click here. To support or donate to Shriners Children's Philadelphia, visit their website. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
an hour ago
- Yahoo
Ascletis Announces Poster Presentations on the Study Results of ASC30 and ASC47 at the 85th Scientific Sessions of American Diabetes Association (ADA)
HONG KONG, June 8, 2025 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces that poster presentations on preliminary studies of its oral small molecule GLP-1 Receptor (GLP-1R) agonist ASC30 and adipose-targeted, muscle-preserving weight loss drug candidate ASC47 will be presented at the 85th Scientific Sessions of American Diabetes Association (ADA) in Chicago, U.S. Details of the Poster Presentations Poster Number: 750-P Abstract Title: ASC30, an Oral GLP-1R Biased Small Molecule Agonist in Participants with Obesity—A First-in-Human Single Ascending Dose Study Session Type: General Poster Session Location: Poster Hall (Hall F1) Presentation Time: Sunday Jun 22, 2025 12:30 PM - 1:30 PM (Chicago Time), i.e., Monday Jun 23, 2025 1:30 AM - 2:30 AM (Beijing Time) Poster Number: 847-P Abstract Title: ASC47, a Muscle-Preserving Weight Loss Drug Candidate for Obesity, in Combination with Semaglutide, Demonstrated Superior Weight Loss to Semaglutide Monotherapy in a Preclinical Model Session Type: General Poster Session Location: Poster Hall (Hall F1) Presentation Time: Sunday Jun 22, 2025 12:30 PM - 1:30 PM (Chicago Time), i.e., Monday Jun 23, 2025 1:30 AM - 2:30 AM (Beijing Time) About ASC30 ASC30 is an investigational GLP-1R biased small molecule agonist and has unique and differentiated properties that enable the same small molecule for both oral tablet and subcutaneous injection administrations. ASC30 is a new chemical entity (NCE), with U.S. and global compound patent protection until 2044. About ASC47 ASC47 is an adipose-targeted, ultra-long-acting subcutaneously (SQ) injected thyroid hormone receptor beta (THRβ) selective small molecule agonist, discovered and developed in-house at Ascletis. ASC47 possesses unique and differentiated properties to enable adipose targeting, resulting in dose-dependent high drug concentrations in the adipose tissue. Topline data from its Phase Ib single subcutaneous injection studies in Australia in participants with elevated low-density lipoprotein cholesterol (LDL-C) (NCT06427590) have been released. The Phase I clinical trial of ASC47 in combination with semaglutide for the treatment of obesity (NCT06972992) is ongoing in the U.S., and the first participants were dosed in May 2025. About the American Diabetes Association (ADA) Established in 1940, the American Diabetes Association (ADA) is dedicated to preventing and curing diabetes and to improving the lives of all people affected by diabetes. It has grown into one of the foremost nonprofit organizations in diabetes advocacy around the world. Its annual Scientific Sessions set the agenda for clinical practice and research innovation. The 85th Scientific Sessions of ADA will be held in Chicago, U.S. from June 20 to 23, 2025. About Ascletis Pharma Inc. Ascletis is an innovative R&D driven biotech listed on the Hong Kong Stock Exchange ( covering the entire value chain from discovery and development to GMP manufacturing. Led by a management team with deep expertise and a proven track record, Ascletis is focused on metabolic diseases by addressing unmet medical needs from a global perspective. Ascletis has multiple clinical stage drug candidates in its metabolic disease pipeline. For more information, please visit Contact: Peter Vozzo ICR Healthcare 443-231-0505 (U.S.) Ascletis Pharma Inc. PR and IR teams +86-181-0650-9129 (China) pr@ ir@ View original content: SOURCE Ascletis Pharma Inc.